BackSunshine Biopharma- Warrants (15/02/2027) Overview
Sunshine Biopharma Inc - Warrants (15/02/2027)

Sunshine Biopharma- Warrants (15/02/2027) Return on Equity

Sunshine Biopharma- Warrants (15/02/2027) (SBFMW) has a ROE of -21.18%, below the Healthcare sector average of 11.15%.

Get informed when a big investor buys or sells

+ Follow

ROE

-21.18%

Return on Equity

-21.18%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Sunshine Biopharma- Warrants (15/02/2027) (SBFMW) FAQ

The latest ROE for SBFMW is -21.18%. That is below the Healthcare sector average of 11.15%. Investors often review this figure alongside Sunshine Biopharma- Warrants (15/02/2027)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SBFMW currently prints -21.18% for ROE, while the sector average sits near 11.15%. That is roughly 289.9% below the sector mean. Large gaps often invite a closer look at Sunshine Biopharma- Warrants (15/02/2027)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Sunshine Biopharma- Warrants (15/02/2027) converts resources into returns. At -21.18%, SBFMW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SBFMW's ROE (-21.18%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sunshine Biopharma- Warrants (15/02/2027)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.